Vertex's success has been achieved largely on the back of its cystic fibrosis (CF) drugs. The company remains the only provider of therapies that treat the underlying genetic cause of the rare genetic ...
Investors had hoped earnings from five of the world’s biggest companies would shake the stocks out of a malaise and provide a fresh jolt for the S&P 500.